reference/12253464

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253464

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	4210
issn	0732-183X 1527-7755
issueIdentifier	25
pageRange	4204-4210
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4204
bibliographicCitation	Hughes T, Saglio G, Branford S, Soverini S, Kim DW, Müller MC, Martinelli G, Cortes J, Beppu L, Gottardi E, Kim D, Erben P, Shou Y, Haque A, Gallagher N, Radich J, Hochhaus A. Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase. J Clin Oncol. 2009 Sep 01;27(25):4204–10. PMID: 19652056; PMCID: PMC4979230.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_974544f622da41112fb35a807531eb2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9b56c415ee0f973e72b149ab0c829c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0910-3730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d42c09f459fa61a2a91d34d12c739e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0626-0834 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84d086c9914fe21bd153776f914353a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5095-7981 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8279-7636 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41e5103c5b916e3a06de408184e3a0d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01006f3c06c69d30dd5f4c56c0209cb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5e8650aeb1804a0df991d97805efa81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c563ada34ff458778846399e9aee4087 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e31814748fd8b81d2fb0411e4ab22fd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4508-0353 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59d538c82374fbed257b6d946297e8e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2be7551cd1a4c84c6815029a10157cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8c1de7da4deb440ed2ecc8697edce38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8cdb97e62ae0f16995c6784026efd22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bb4277f61d43572760272c5221557be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76d9df83c042b46de475cc8f9c86efae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a997977bd8b3ab3316f7cb317a9116b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1046-3514 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa685d0599ebeee341aa7d3b3a724e3c
date	2009-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4979230 https://doi.org/10.1200/jco.2009.21.8230 https://pubmed.ncbi.nlm.nih.gov/19652056
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0024527 http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0360009
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016044Q000037 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D016044Q000235 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D015464Q000201 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D001315 http://id.nlm.nih.gov/mesh/D015971 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D007723 http://id.nlm.nih.gov/mesh/D015973
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613

Total number of triples: 82.